T1	Participants 36 81	recipients of extended criteria donor kidneys
T2	Participants 84 158	Patients in the BENEFIT-EXT study received extended criteria donor kidneys
T3	Participants 271 466	Patients who remained on assigned therapy through year 3 were eligible to enter a long-term extension (LTE) study. Three hundred four patients entered the LTE (n = 104 MI; n = 113 LI; n = 87 CsA)
